Related Experiment Video
Updated: Sep 17, 2025

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
Published on: January 5, 2024
Fibromyalgia: do I tackle you with complementary medicines?
Julien Nizard1, Françoise Laroche2, Fabrice Berna3
1Nantes Université; Nantes University Hospital, Multidisciplinary Pain, Palliative and Integrative Care Department, UIC 22; UMRS INSERM-Nantes Université-Oniris 1229 RMeS Regenerative Medicine and Skeleton; Collège Universitaire des Médecines Intégrative et Complémentaires (CUMIC), Nantes, France.
Fibromyalgia patients often use complementary medicine (CM) without informing doctors. This review defines CM, discusses risks and benefits, and offers guidance for safe integration into fibromyalgia management.
Area of Science:
- Pain Management
- Integrative Medicine
Background:
- Fibromyalgia management guidelines emphasize graded care and integrating nonpharmacological treatments and complementary medicine (CM).
- Patients often seek CM due to medication side effects, persistent symptoms, or a perception of safety and naturalness.
- Patients frequently withhold CM use from physicians due to fear of negative reactions, leading to potential risks.
Purpose of the Study:
- To provide updated definitions of nonpharmacological treatments and CM used by fibromyalgia patients.
- To discuss the potential benefits, risks, and challenges in evaluating these complementary medicine practices.
- To propose a structured approach for healthcare providers to discuss CM with fibromyalgia patients.
Main Methods:
- This narrative review synthesizes current literature on nonpharmacological treatments and CM for fibromyalgia.
- It includes updated definitions, risk-benefit analyses, and evaluation challenges.
- A structured discussion framework for patient-provider communication is proposed.
Main Results:
- Nonpharmacological treatments and CM are widely used by fibromyalgia patients, often without physician awareness.
- These practices carry potential benefits but also significant risks, including lack of regulation and safety concerns.
- Challenges exist in evaluating the efficacy and safety of many CM modalities.
Conclusions:
- Healthcare providers should proactively discuss nonpharmacological treatments and CM with fibromyalgia patients.
- Assessing patient expectations, motivations, and prior experiences is crucial for adherence and safety.
- Identifying "red flags" and guiding patients toward qualified practitioners and safe environments is essential.
More Related Videos
04:50Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
04:28Warm Moxibustion and Scraping as a Traditional Chinese Medicine Therapy for Cervical Spondylosis Treatment
Published on: June 27, 2025
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...